Global prophylactic vaccination programmes have helped to curb new hepatitis B virus(HBV)infections.However,it is estimated that nearly 300 million people are chronically infected and have a high risk of developing he...
Hepatitis B virus(HBV)infection,although preventable by vaccination,remains a global health problem and a major cause of chronic liver disease.Although current treatment strategies suppress viral replication very effi...
Supported by Fundacao Amazonia de Amparo a Estudos e Pesquisa(FAPESPA),No.174/2014
AIM To establish a permanent piwi like RNA-mediated genesilencing 1(PIWIL1) gene knockout in AGP01 gastric cancer cell line using CRISPR-Cas9 system and analyze phenotypic modifications as well as gene expression alte...
Supported by the United States National Institutes of Health(NIH),No.F32-DK097855(to Schaefer EAK),No.T32-DK008191(to Motola DL),No.K08-DK088951(to Peng LF),and No.K24-DK078772(to Chung RT)
AIM To characterize the role of apolipoprotein B100(apoB 100) in hepatitis C viral(HCV) infection. METHODS In this study, we utilize a gene editing tool, transcription activator-like effector nucleases(TALENs), to gen...
Despite a decline in the overall incidence of gastric cancer(GC),the disease remains the second most common cause of cancer-related death worldwide and is thus a significant global health problem.The best means of imp...
National Natural Science Foundation of China,No.30271477,No.30572162
AIM: To identify the relationship between DNA hyper- methylation and histone modification at a hyperme- thylated, silenced tumor suppressor gene promoter in human gastric cancer cell lines and to elucidate whether al...
Supported by the Guangdong Provincial Scientific Research Grants: No. 2004B30301002, No. 2007B030702012 and No. 04300330
AIM: To observe the gene silencing mediated by the specific shRNA targeted against β-catenin and its effect on cell proliferation and cycle distribution in the human colon cancer cell line Colo205. METHODS: Two shRNA...
Supported in part by research grants from the National Natural Science Foundation of China,No.30300298;the National Natural Science Foundation of China's Joint Research Fund for Overseas Chinese Young Scholars,No.30228026
AIM: TO inhibit the expression of vascular endothelial growth factor (VEGF) in colon cancer cell line by RNA interference (RNAi).METHODS: Followed the service of E-RNAi, we designed and constructed two kinds of ...